Publication Details
Overview
 
 
Leon Verbruggen, Leon Verbruggen, N. Dumarey, N. Dumarey, Hilde Van De Velde, Hilde Van De Velde, V. Rebmann, V. Rebmann, J. Flament, J. Flament, C. Van Waeyenberge, C. Van Waeyenberge, H. Grosse-Wilde, H. Grosse-Wilde, Christian Demanet, Christian Demanet
 

Contribution to journal

Abstract 

We investigated correlations between soluble HLA-DR (sHLA-DR) molecules and several clinical, biological and genetic parameters associated with rheumatoid arthritis (RA) disease activity. Serum sHLA-DR concentrations were determined in 146 samples from 89 RA patients by an ELISA format, using an antibody combination of mouse and rat monoclonal anti-human HLA-DR antibodies. The mean sHLA-DR serum level in RA patients was significantly increased with 277±19 ng/ml compared to 142±13 ng/ml of 80 healthy controls (P

Reference